BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17596548)

  • 1. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer.
    Nijhuis ER; Nijman HW; Oien KA; Bell A; ten Hoor KA; Reesink-Peters N; Boezen HM; Hollema H; van der Zee AG
    J Clin Pathol; 2007 Jul; 60(7):824-30. PubMed ID: 17596548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
    Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
    Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
    Ohrling K; Edler D; Hallström M; Ragnhammar P
    Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
    Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
    Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression in early stage cervical cancer.
    Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
    Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
    Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
    Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.
    González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E
    Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
    Zhang X; Li F; Zhu PL
    Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.
    Juretzka MM; Jensen KC; Longacre TA; Teng NN; Husain A
    Gynecol Oncol; 2004 Apr; 93(1):107-11. PubMed ID: 15047221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of CDC6 and hMSH2 in cervical carcinoma].
    Wang WX; Zhang WJ; Peng ZL; Yang KX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):857-60. PubMed ID: 19950599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
    J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
    Eggen T; Arnes M; Moe B; Straume B; Orbo A
    Int J Gynecol Pathol; 2007 Oct; 26(4):447-56. PubMed ID: 17885497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.